Session 2: Rewards and Challenges of Scale-up and Large Scale Fermentation Processes
	
					
		
	
		
	Monday, November 9, 2015: 8:00 AM-11:30 AM
	Grand Ballroom F-G (Hilton Clearwater Beach Hotel)
	
	
	
	
	
		Convener:
			
				
					
					
						Christopher McDowell 
						
						  -	Novozymes North America 	
						
						
					
				
			
 
		Co-conveners:
			
				
					
					
						Dale Brown 
						
						  -	Dow AgroSciences LLC 	
						
						
					
				
					 and 
					
						Billy Allen 
						
						  -	Eli Lilly and Company 	
						
						
					
				
			
 
		
		
			8:00 AM
		
	
	
	
		
		
				Modelling large-scale bubble column bioreactors using computational fluid dynamics
			
D. McClure*, J. Kavanagh, D. Fletcher and G. Barton, The University of Sydney, Sydney
D. McClure*, J. Kavanagh, D. Fletcher and G. Barton, The University of Sydney, Sydney
		
			8:25 AM
		
	
	
	
		
		
				New approaches to better understanding large scale recombinant protein production
			
S.M. Stocks* and M. Albaek, Novozymes A/S, Bagsværd, Denmark
				
			
		
	
S.M. Stocks* and M. Albaek, Novozymes A/S, Bagsværd, Denmark
		
			9:20 AM
		
	
	
	
		
		
				Life-cycle fossil energy consumption and greenhouse gas emissions of bioderived chemicals and their conventional counterparts
			
F. Adom*, J. Dunn, H. Jeongwoo and N. Sather, Argonne National Laboratory, Lemont, IL
				
			
		
	
F. Adom*, J. Dunn, H. Jeongwoo and N. Sather, Argonne National Laboratory, Lemont, IL
		
			9:45 AM
		
	
	
	
		
		
				A Comparison of High Cell Density Fed-Batch Fermentations Involving Recombinant Escherichia coli, Bacillus subtilis and Corynebacterium glutamicum Under Well-Mixed Small-Scale and Simulated Poorly Mixed Large-Scale Conditions
			
C. Hewitt*, Aston University, Birmingham; A. Nienow, University of Birmingham, Edgbaston; C. Rielly and W. Olughu, Loughborough University, Loughborough; S.M. Stocks, Novozymes A/S, Bagsværd, Denmark
				
			
		
	
C. Hewitt*, Aston University, Birmingham; A. Nienow, University of Birmingham, Edgbaston; C. Rielly and W. Olughu, Loughborough University, Loughborough; S.M. Stocks, Novozymes A/S, Bagsværd, Denmark
		
			10:10 AM
		
	
	
	
		
		
				Challenges in Live Whole Bacteria Vaccines Development and Manufacturing
			
L. Chew* and P. Shabram, PaxVax Inc, San Diego, CA; M. Leckenby, PaxVax Berna GmbH, Thörishaus, Switzerland
				
			
		
	
L. Chew* and P. Shabram, PaxVax Inc, San Diego, CA; M. Leckenby, PaxVax Berna GmbH, Thörishaus, Switzerland
		
			10:35 AM
		
	
	
	
		
		
				Scale-up of Renewable Chemical Manufacturing Processes
			
J. Zahn*, Dupont Tate & Lyle Bio Products, LLC, Loudon, TN; K.J. Sanford, G. Chotani and N. Danielson, DuPont, Palo Alto, CA
				
			
		
	
J. Zahn*, Dupont Tate & Lyle Bio Products, LLC, Loudon, TN; K.J. Sanford, G. Chotani and N. Danielson, DuPont, Palo Alto, CA
	
	
	See more of: Invited Papers
	
	
	
	
				